US Resumes Vital Health Aid to Global Agencies After Funding Halt
US resumes some vaccine and health aid to UNICEF, Gavi, and WFP, though funding remains below previous levels.
US resumes some vaccine and health aid to UNICEF, Gavi, and WFP, though funding remains below previous levels.
Merck is working with African and Indian firms to produce affordable generic versions of its new HIV prevention pill.
US to phase out HIV/AIDS funding for South Africa, impacting prevention and treatment programs.
Global health response to Ebola has improved since 2014-16, with better vaccines and coordination, but challenges remain.
China's capacity to respond to the Ebola outbreak in East Africa presents a strategic opportunity amid potential US withdrawal.
A new twice-yearly HIV prevention drug has arrived in Zambia, but concerns linger over the country's strained health system.
Emerging Hantavirus and Ebola cases highlight global health system vulnerabilities, demanding enhanced international cooperation and preparedness.
WHO declares Ebola outbreak in Congo and Uganda a Public Health Emergency of International Concern, advising against non-essential travel.
Ebola crisis sparks debate on global health double standards, with Africans citing unequal response and resource allocation.
Oxford University and Serum Institute of India partner on a new multi-stage malaria vaccine, R78C, aiming for broad accessibility.